Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
09/2003
09/04/2003CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/03/2003EP1339798A2 Sulfonated diarylrhodamine dyes
09/03/2003EP1339720A2 Use of oxabicyclo 2.2.1]heptane derivatives as pesticidal agents
09/03/2003EP1339699A1 Substituted amidoalkyl uracils and the use thereof
09/03/2003EP0285671B1 Pyridine derivatives
09/03/2003CN1440414A Synthesis of cuttlefish compound
09/03/2003CN1440413A Method for preparing (+)-biotine
09/03/2003CN1440409A Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
09/03/2003CN1440401A Amino substituted dibenzothiophene derivatives for treatmnt of disorders mediated by NP Y5 receptor
09/02/2003US6613905 Chemokine receptor antagonists and methods of use therefor
09/02/2003US6613900 Cephalotaxane derivatives and process for their preparation
09/02/2003US6613776 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease
09/02/2003US6613765 Use of NK-1 receptor antagonists for treating major depressive disorders
09/02/2003US6613761 (3R,5S)-N- methanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl) -1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4, 1-benzoxazepine-3-acetamide, used as antilipemic agents and enzyme inhibitors
09/02/2003US6613537 Diagnosis of diabetes
09/02/2003CA2216796C Quinazoline derivatives
08/2003
08/28/2003WO2003070855A1 Organic electroluminescent element
08/28/2003WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003WO2003031447A3 Pyrimidine derivatives
08/28/2003US20030162972 Pyridyl alkane acid amides as cytostatics and immunosupressives
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162958 Process for preparing a compound containing a heteroaromatic group with one or more ether substituents
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162784 Pyridazinone aldose reductase inhibitors
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/27/2003EP1338599A1 Optically pure analogues of Camptothecin
08/27/2003EP1338336A1 Catalysts comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalysts
08/27/2003EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
08/27/2003EP1140944B1 Epothilone derivatives and their use as antitumor agents
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0946567B1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
08/27/2003CN1438997A Inhibitors of 11-beta-hydroxy steroid dehydrogenase typeÔàá"
08/27/2003CN1438887A 水性液体制剂 The aqueous liquid preparation
08/27/2003CN1438886A Ophthalmic solution
08/27/2003CN1119348C Glucocorticoid derivatives, their composition and use
08/26/2003US6610713 Treating cell with cholinergic agonist
08/26/2003US6610691 Carboxylic acid derivatives, their production and use
08/26/2003US6610677 Enhancing glycogen synthesis, lowering blood levels of glucose, treating colon, ovarian, or breast cancer, treating diabetes, treating schizophrenia
08/21/2003WO2003068778A1 A process for the preparation of 10-hydroxy-9-n,n-dimethylaminomethyl-5-(2'-fluoroethoxy)-20(s)-camptothecin hydrochloride
08/21/2003WO2003068765A2 Improved process for the production of dihydropyridines
08/21/2003WO2003068748A1 Novel pyridine- and quinoline-derivatives
08/21/2003WO2002094844A3 Antiviral nucleosides
08/21/2003WO2002036573A3 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
08/21/2003US20030158405 N-benzhydryl indole compounds
08/21/2003US20030158219 N-substituted spiropiperidine compounds as ligands for ORL-1 receptor
08/21/2003US20030158193 Therapeutic treatment of gastrointestinal inflammatory disorders, ulcer disorders
08/21/2003US20030158173 NK 1 antagonists
08/21/2003US20030158153 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
08/21/2003US20030157167 Oxymorphone controlled release formulations
08/21/2003CA2476220A1 Improved process for the production of dihydropyridines
08/20/2003EP1173520B1 Novel amidopyrylium fluorescence dyes
08/20/2003EP1086106B1 Furopyridine derivatives and their therapeutical use
08/20/2003EP0946569B1 Cycloaliphatic epoxy compounds
08/20/2003CN1437603A Oxazolidinone derivatives with antibiotic activity
08/20/2003CN1437602A Compounds for treating impaired fundic relaxation
08/20/2003CN1437588A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type l
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1118460C Pyrimidine derivatives as 5HT2C-receptor antagonists
08/20/2003CN1118456C 1,2-dihydro-2-oxoquinoline derivatives
08/19/2003US6608211 Pesticides and herbicides; well tolerated by plants
08/19/2003US6608197 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
08/19/2003US6608098 Isoindole derivatives
08/19/2003US6608076 Treating topoisomerase I inhibitor-related disease in mammals
08/19/2003US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
08/19/2003US6608056 Phosphatidylinositol 3-kinase inhibitors and carcinostatic agents
08/19/2003US6608053 Phosphatidylinositol 3-kinase (PI3K) inhibitors/anticancer agents such as N-(2-(3-benzenesulfonylaminophenyl)-4-morphoniloquinazolin-6-yl)acetamide
08/19/2003CA2079376C (bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/14/2003WO2003067259A1 E2 displacement assay for identifying inhibitors of hpv
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003066604A2 Novel aryl- and heteroarylpiperazines
08/14/2003WO2003066592A1 Gamma secretase inhibitors
08/14/2003WO2003066099A1 2,4,6-triamino-1,3,5-triazine derivative
08/14/2003WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003WO2003053941A3 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
08/14/2003US20030153773 Process for the production of dihydropyridines
08/14/2003US20030153604 Anticoagulants
08/14/2003US20030153595 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
08/14/2003US20030153584 Such as cyclo-D-phenylglycyl-L-(2-(amino-3-mercaptobutanoic acid))
08/14/2003US20030153566 Adenosine receptor agonist
08/14/2003CA2478423A1 Gamma secretase inhibitors
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2474214A1 Novel aryl- and heteroarylpiperazines
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/13/2003EP1334732A1 Pharmaceutical preparation containing copolyvidone
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1216244B1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists
08/13/2003EP1165540B1 Tetrahydropyran derivatives and their use as therapeutic agents
08/13/2003EP0966458B1 Sulfonated xanthene derivatives
08/13/2003EP0588859B1 Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
08/13/2003CN1436193A Antitumoral ecteinascidin derivs
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1435465A Yellow light emitting compound and organic electro-luminescent device thereof
08/13/2003CN1117755C Spiroazabicyclic heterocyclic compounds, method for preparing same and use thereof
08/13/2003CN1117753C Substd. benzimidazoles, production and use thereof as agents for combating parasitic protozoas
08/12/2003US6605720 Process for making spirolactone compounds
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605612 Cardioprotective phosohonates and malonates
1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 298